Abnormalities in the expression of cytokines and their receptors in patients with myelodysplastic syndromes.

被引:0
|
作者
FontenayRoupie, M
Dreyfus, F
机构
来源
PATHOLOGIE BIOLOGIE | 1997年 / 45卷 / 07期
关键词
cytokines; receptors;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Abnormalities of the expression of cytokines and their receptors seen in myelodysplastic syndromes (MDS) are reviewed. Autocrine and paracrine secretion of growth factors, most notably GM-CSF and IL-6, has been identified as a factor in clone expansion in young pediatric patients with chronic myelomonocytic leukemia. Mutations affecting cFMS, the receptor for M-CSF, have also been demonstrated. The other reported abnormalities have been found in too small a number of cases to explain the cell growth and differentiation disorders seen during the course of MDS. It remains possible, however, that a more detailed study of signal transduction pathways might detect functional abnormalities explaining the contrast between the small number of reported cases with abnormalities at the cytokine and cytokine receptor sites and the cell growth and differentiation disorders that are prominent in MDS.
引用
收藏
页码:569 / 572
页数:4
相关论文
共 50 条
  • [41] Characterization of defective in vitro megakaryocytic development in patients with myelodysplastic syndromes.
    Hofmann, WK
    Kalina, U
    Wagner, S
    Ries, C
    Hoelzer, D
    Ottmann, OG
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 454 - 454
  • [42] Prognostic relevance of cytogenetic subgroups in 357 patients with myelodysplastic syndromes.
    Haase, D
    Schanz, J
    Wulich, J
    Schoch, C
    Freund, M
    Haferlach, T
    Wormann, B
    Staib, P
    Lentini, G
    Bartels, H
    Geissler, RG
    Germing, U
    Dorges, U
    Fonatsch, C
    Hiddemann, W
    BLOOD, 1997, 90 (10) : 2232 - 2232
  • [43] Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes.
    Urrutia, Samuel
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jabbour, Elias
    Chien, Kelly Sharon
    Hammond, Danielle
    Bueso-Ramos, Carlos E.
    Khoury, Joseph
    Patel, Keyur P.
    Montalban-Bravo, Guillermo
    Wei, Yue
    Colla, Simona
    Short, Nicholas James
    Daver, Naval Guastad
    Borthakur, Gautam
    Kadia, Tapan M.
    Pierce, Sherry
    Wierda, William G.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Determination of LTC-IC numbers in patients with myelodysplastic syndromes.
    Sato, T
    Kim, S
    Selleri, C
    Young, NS
    Maciejewski, JP
    BLOOD, 1996, 88 (10) : 1338 - 1338
  • [45] Myelodysplastic syndromes. Diagnosis and therapeutic strategies
    Aul, C
    Giagounidis, A
    Germing, U
    Ganser, A
    MEDIZINISCHE KLINIK, 2002, 97 (11) : 666 - 676
  • [46] Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
    Pollio, B.
    Ciriello, M. M.
    Fruttero, A.
    Geuna, M.
    Iavarone, A.
    Omede, P.
    Pautasso, M.
    Pollono, A. M.
    Santagostino, A.
    Garbaccio Ioria, G.
    Stacchini, A.
    Gioia, D.
    Ferrero, D.
    Marmont, F.
    Gallamini, A.
    Saglio, G.
    Levis, Alessandro
    Girotto, M.
    BLOOD, 2006, 108 (11) : 740A - 740A
  • [47] Antithymocyte globulin for the treatment of patients with 'low risk' myelodysplastic syndromes.
    Killick, S
    Marsh, JCW
    Cavenagh, J
    Mijovic, A
    Mufti, G
    Gordon-Smith, EC
    Bowen, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 69 - 69
  • [48] ACUTE MYELOID LEUKEMIA PROGRESSION IN ARGENTINEAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.
    Enrico, A.
    Flores, M. G.
    Arbelbide, J.
    Kornblihtt, L.
    Crisp, R.
    Correa, W.
    Gonzalez, J.
    Bengio, R.
    Narbaitz, M.
    Pardo, L.
    Watman, N.
    Bestach, Y.
    Rosenhain, M.
    Basquiera, A.
    Larripa, I.
    Iastrebner, M.
    Belli, C.
    HAEMATOLOGICA, 2015, 100 : 483 - 483
  • [49] The prognostic value of LDH in myelodysplastic syndromes.
    Wimazal, F
    Sperr, WR
    Kundi, M
    Fonatsch, C
    Thalhammer-Scherrer, R
    Wessel, S
    Meidlinger, P
    Schwarzinger, I
    Geissler, K
    Lechner, K
    Valent, P
    BLOOD, 1999, 94 (10) : 288B - 288B
  • [50] Study on the burden of abnormal hematopoietic clone of the patients with myelodysplastic syndromes.
    Shao, ZH
    Wang, HQ
    Shi, J
    Cao, YR
    Liu, H
    Bai, H
    Tu, MF
    Xing, LM
    Liu, SH
    Sun, J
    Jia, HR
    BLOOD, 2005, 106 (11) : 305B - 305B